Early Involvement of Patients in Pharmaceutical Research and Development for Rare Diseases.
Ergomed acquires MedSource, an award-winning, oncology-focused U.S. based CRO.
Ergomed is a global, full-service CRO with a strong heritage in Europe and the United States of America.
Industry world-renowned provider for pharmacovigilance and medical information services.
Orphan Drug Development
Therapeutic Area Expertise
In-house Phase I-IV Clinical Development
Unique Site & Physician Support Solutions